CIK 0001768224 · Accelerated filer<br>Smaller reporting company
Arcturus Therapeutics Holdings Inc.
Sign in to watch- Ticker
- ARCT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 8589002660
- Business address
- 10285 SCIENCE CENTER DRIVE, SAN DIEGO, CA
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-12-18 | Kurata Lance Chief Legal Officer | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2020-12-09 | Ultragenyx Pharmaceutical Inc. Director | Sale | −357,745 | $94.97 | $34.0M | 2,200,000 |
| 2020-12-08 | Ultragenyx Pharmaceutical Inc. Director | Sale | −442,255 | $105.54 | $46.7M | 2,557,745 |
| 2020-12-01 | Chivukula Pad Chief Scientific Officer & COO | Sale | −10,000 | $96.19 | $962K | 692,548 |
| 2020-11-02 | Chivukula Pad Chief Scientific Officer & COO | Sale | −10,000 | $55.28 | $553K | 702,548 |
| 2020-10-01 | Chivukula Pad Chief Scientific Officer & COO | Sale | −10,000 | $42.83 | $428K | 712,548 |
| 2020-09-03 | Chivukula Pad Chief Scientific Officer & COO | Sale | −10,000 | $45.16 | $452K | 722,548 |
| 2020-08-10 | Kurata Lance Chief Legal Officer | Grant or award · Stock Option (right to buy) | +90,000 | 90,000 | ||
| 2020-06-22 | Parschauer Karah Herdman Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2020-06-22 | Marquet Magda Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2020-06-22 | HOLMES EDWARD W Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2020-06-22 | BARLOW JAMES F Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2020-06-22 | FARRELL PETER C Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2020-06-12 | Kummerfeld Keith C See Remarks | Purchase | +450 | $33.33 | $15K | 950 |
| 2020-06-10 | Payne Joseph E President and CEO | Purchase | +1,000 | $31.69 | $32K | 1,475,097 |
| 2020-06-10 | SASSINE ANDY Chief Financial Officer | Purchase | +5,000 | $29.74 | $149K | 273,245 |
| 2020-05-20 | Ultragenyx Pharmaceutical Inc. Director | Option exercise | +600,000 | $16.00 | $9.6M | 3,000,000 |
| 2020-05-20 | Ultragenyx Pharmaceutical Inc. Director | Option exercise · Option (Right to Buy) | −600,000 | 0 | ||
| 2020-02-18 | Chivukula Pad Chief Scientific Officer & COO | Grant or award · Stock Option (right to buy) | +60,000 | 60,000 | ||
| 2020-02-18 | Kummerfeld Keith C See Remarks | Grant or award · Stock Option (right to buy) | +10,000 | 10,000 |
Page 8 of 9 · 178 trades